All lobbying filings

VENN STRATEGIES

VENN STRATEGIES filed a Q4 termination report for MAGNUS MEDICAL INC. on April 3, 2026, reporting $50,000 in lobbying income.

Lobbying for MAGNUS MEDICAL INC. · medical device company developing rapid-acting brain stimulation technology.

All filings by VENN STRATEGIES · Everything MAGNUS MEDICAL INC. has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Apr 3, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to reimbursement rates for medical devices.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.